Skip to main content
. 2017 Dec 22;96(51):e9431. doi: 10.1097/MD.0000000000009431

Figure 3.

Figure 3

After treatment with pembrolizumab, the patient experienced a skin rash. Skin rash was detected 4 days after his admission, mainly in the lower limbs.